its structure and precise mechanisms of action have remained unknown until now. The lack of this information has been a significant gap in research on eye diseases, especially those leading to ...

For some creatures, a lost body part is not necessarily a permanent affair. Salamanders can regrow limbs and zebrafish can rebuild their retinas. Yet mammals — including humans — are largely stuck ...

New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy exists for this rare inherited disease ...

Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one ...

Retinitis Pigmentosa (RP) is a rare genetic eye disorder that causes the retina’s cells to break down over time, leading to ...

Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design ...

New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa.

In mice both with retinitis pigmentosa (RP) and lab-grown human retina tissue with damage akin to age-related macular degeneration (AMD), a daily drop prevented photoreceptors in the eye from ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

For individuals with inherited eye disorders such as retinitis pigmentosa or macular degeneration ... Although promising, further studies are needed to explore the mechanisms underlying hNRSC-mediated ...

"We are excited by the therapeutic benefits seen in retinitis pigmentosa patients with progressive and permanent loss of photoreceptors and without any treatment option," said Dr. Santosh ...